Njengezwe lesine elinabantu abaningi emhlabeni, i-Indonesia iyizwe elithinteke kakhulu eNingizimu-mpumalanga ye-Asia.I-Food and Drug Administration (BPOM) yase-Indonesia ithe maduze izovuma ukusetshenziswa okuphuthumayo komgomo we-sinovac.Phambilini umnyango uthe unethemba lokunikeza imvume ephuthumayo yokugoma ngemuva kokufunda imininingwane yesikhashana evela ezivivinyweni zomtholampilo e-Indonesia, Brazil naseTurkey.I-Indonesia iyalele imithamo eyizigidi eziyi-125.5 yomuthi wokugomela i-COVID-19 ovela eSinovac.Imithamo eyizigidi ezintathu isitholakele kuze kube manje futhi izosatshalaliswa ezweni lonke kusukela ngoJanuwari 3, kusho umbiko.USolwazi Wiku, okhulumela ithimba likahulumeni wase-Indonesia lokuphendula i-COVID-19, uthe ngoLwesihlanu ukusatshalaliswa kwemithi yokugomela i-sinovac ngaphambi kokuthi i-BPOM inikeze ukugunyazwa kokusetshenziswa kwezimo eziphuthumayo wukuthuthukisa ukusebenza kahle kwesikhathi nokuqinisekisa ukutholakala kwemithi yokugoma ngokulinganayo, kubika i-VOA.

Uhulumeni uzibekele umgomo wokugoma imithamo eyizigidi ezingama-246 yomgomo we-COVID-19, kusho iJapan Times.Ngaphezu kwe-Sinovac, uhulumeni uhlela nokuthola imigomo kubakhiqizi abafana ne-Pfizer ne-Astrazeneca, futhi ucabanga ukuthuthukisa imigomo yasekhaya ukuze angezelele izimpahla.